Cargando…

Marker or mediator? Changes in endotoxin activity as a predictor of adverse outcomes in critical illness

Detalles Bibliográficos
Autores principales:	Klein, D, Derzko, A, Seely, A, Foster, D, Marshall, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098311/ http://dx.doi.org/10.1186/cc3224

Ejemplares similares

Rates of agreement of endotoxin, procalcitonin and lactate in septic and non-septic critically ill patients
por: Foster, D, et al.
Publicado: (2005)

Copeptin as a marker of shock and predictor of adverse outcome in critically ill patients
por: Meyer, B, et al.
Publicado: (2008)

Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence
por: Marshall, John C, et al.
Publicado: (2002)

Endotoxin activity assay and polymyxin B hemoperfusion use in a cohort of critically ill patients
por: Cutuli, SL, et al.
Publicado: (2014)

Endotoxin assay with endotoxin scattering photometry is one of the diagnostic markers of sepsis
por: Kase, Y, et al.
Publicado: (2010)

Admission hypomagnesemia as a mortality predictor in medical critically ill patients
por: Permata Sari, A, et al.
Publicado: (2014)

New sepsis-related marker: endotoxin activity assay
por: Ikeda, T, et al.
Publicado: (2010)

Measuring endotoxin with newly developed endotoxin scattering photometry
por: Kase, Y, et al.
Publicado: (2008)

Procalcitonin as a marker of infection in critically ill patients
por: Koukiasa, P, et al.
Publicado: (2004)

Procalcitonin: a prognostic marker for critically ill
por: Bhattacharyya, M, et al.
Publicado: (2009)

Eosinopenia as a marker of sepsis and mortality in critically ill patients
por: Savitskiy, A, et al.
Publicado: (2015)

The calculated ion gap: a novel predictor of mortality in the critically ill surgical patient
por: Leitch, F, et al.
Publicado: (2007)

Magnesium at admission: is it an outcome marker in the critically ill patient?
por: Passakiotou, M, et al.
Publicado: (2005)

Predictors of poor outcomes in critically ill patients with hematologic malignancy
por: Cornish, M, et al.
Publicado: (2015)

Plasma DNA concentration as an early predictor of outcome in critically ill septic patients
por: El-Akabawy, H, et al.
Publicado: (2011)

Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients
por: Wort, S, et al.
Publicado: (2004)

Lactate and base deficit are predictors of mortality in critically ill patients with cancer
por: Hajjar, LA, et al.
Publicado: (2011)

Assessment of the mottling score as a mortality predictor in critically ill patients
por: de Moura, E Bastos, et al.
Publicado: (2013)

Predictors of in-hospital mortality in critically ill patients with secondary and tertiary peritonitis
por: Ballús Noguera, J, et al.
Publicado: (2015)

The apache ii and serum sodium levels as predictors of mortality in the surgical critically ill patients
por: Basile-Filho, A, et al.
Publicado: (2015)

Procalcitonin: analysis of diagnostic specificity and effectivity in comparison with other markers of inflammation in the critically ill
por: Valenta, J, et al.
Publicado: (2006)

Insufficient autophagy relates to mitochondrial dysfunction, organ failure and adverse outcome in an animal model of critical illness
por: Gunst, J, et al.
Publicado: (2012)

Validation of HbA1c as a diagnostic marker for diabetes in the critically ill
por: Gornik, I, et al.
Publicado: (2010)

Endotoxin removal by hemoperfusion in septic shock
por: Adamik, B, et al.
Publicado: (2011)

Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients
por: Focà, A, et al.
Publicado: (2012)

Use of anti-Xa factor titration as efficacy marker of enoxaparin in critically ill patients
por: Lage, S, et al.
Publicado: (2006)

Clinical aspects and predictors of mortality of Pseudomonas aeruginosa pneumonia in a cohort of critically ill patients
por: De Pascale, G, et al.
Publicado: (2011)

Is fibrinolysis a predictive marker of multiple organ failure in critically ill patients?
por: Bouckaert, Y, et al.
Publicado: (2005)

Procalcitonin in the critically ill
por: Kazda, A, et al.
Publicado: (2005)

Mid-regional pro-atrial natriuretic peptide is a strong predictor of outcome in an unselected cohort of critically ill patients
por: Meyer, B, et al.
Publicado: (2007)

Angiopoietin-2 is a mediator involved in the advent of hypotension following endotoxin shock
por: Carrer, PD, et al.
Publicado: (2009)

Newly developed endotoxin measurement method (endotoxin activity assay) may reflect the severity of sepsis
por: Murayama, H, et al.
Publicado: (2009)

Predictors of renal recovery in critically ill patients with AKI: observations from the ongoing FBI clinical trial
por: Robinson, S, et al.
Publicado: (2015)

Intensive insulin therapy and brief hypoglycemia do not increase neurological injury markers in critically ill children
por: Gielen, M, et al.
Publicado: (2010)

Critically ill patients with severe acute respiratory syndrome (SARS) in a designated national SARS ICU: clinical features and predictors for mortality
por: Tai, D, et al.
Publicado: (2004)

The Critically Ill Adults scale
por: Schoonderbeek, J, et al.
Publicado: (2005)

Long-term outcome of delirium in critically ill patients
por: Wolters, A, et al.
Publicado: (2013)

Adverse drug events in the critical care unit
por: Seynaeve, S, et al.
Publicado: (2010)

New markers of inflammation-induced renal injury subside when endotoxin tolerance develops in humans as measured by urine proteomics
por: Heemskerk, S, et al.
Publicado: (2010)

Systemic and regional effects of levosimendan and arginine–vaopressine in endotoxin-treated rabbits
por: Kaskos, H, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_i07fm33usvp43ue40sblveqmj4